Osteopontin Gene Is Expressed in the Dermal Papilla of Pelage Follicles in a Hair-Cycle-Dependent Manner

    Da Wen Yu, Tian Yang, Tadashige Sonoda, Yanling Gong, Qiong Cao, Kevin J. Gaffney, Pamela J. Jensen, Irwin M. Freedberg, Robert M. Lavker, Tung-Tien Sun
    Image of study
    TLDR The osteopontin gene is active in a specific part of rat hair follicles during a certain hair growth phase and might affect hair cycle and diseases.
    The 2001 study found that the osteopontin (OPN) gene is expressed in the dermal papilla of rat pelage follicles specifically during the catagen phase of the hair cycle, but not during the anagen or telogen phases. OPN, an extracellular matrix protein, may play a role in cell attachment, signaling, and tissue survival, and could be involved in the aggregation of dermal papilla cells or protection against apoptosis during catagen. The study also noted that androgen suppresses OPN expression, which could be relevant to hair diseases like androgenic alopecia. The research involved comparing OPN mRNA levels in cultured rat vibrissa dermal papilla cells, which were high, to those in cultured rat skin fibroblasts, where OPN mRNA was not detected. This study enhances the understanding of hair cycle regulation and the potential mechanisms underlying hair disorders.
    Discuss this study in the Community →

    Research cited in this study

    9 / 9 results

    Related Community Posts Join

    6 / 19 results

      community Coegin Pharma to release Follicopeptide (FOL005) by Q2 2025

      in Treatment  123 upvotes 11 months ago
      Follicopeptide (FOL005) by Coegin Pharma will launch as a cosmetic hair growth treatment by Q2 2025, showing similar efficacy to finasteride. Users discuss the benefits and skepticism of releasing hair loss treatments as cosmetics rather than drugs.

      community Found an interesting little article

      in Research/Science  6 upvotes 1 year ago
      A new painless microneedle patch shows promise in reversing hair loss. The discussion focuses on potential new treatments beyond common options like Minoxidil, finasteride, and RU58841.

      community IGF-1 and Peptides? Miracle molecule waiting to be found

      in Research/Science  8 upvotes 1 week ago
      The conversation discusses potential hair loss treatments focusing on stimulating IGF-1 at the follicle level using growth-factor cocktails and engineered peptides, such as Acetyl Tetrapeptide-3, Copper Tripeptide-1, Oligopeptide-20, Thymosin-β4, and Palmitoyl Tetrapeptide-7. It suggests that device-assisted delivery methods like microneedling may enhance effectiveness.

    Similar Research

    5 / 189 results